Men | ||||||||
---|---|---|---|---|---|---|---|---|
ATPIII | IDF | |||||||
MS criteria | Total | Without CL | With CL | p value | Total | Without CL | With CL | p value |
WC [n, (%)] | 43 (18.0%) | 21 (24.7%) | 22 (14.3%) | 0.045 | 98 (41.0%) | 42 (49.4%) | 56 (36.4%) | 0.050 |
TG [n, (%)] | 197 (82.4%) | 65 (76.5%) | 132 (85.7%) | 0.072 | 197 (82.4%) | 65 (76.5%) | 132 (85.7%) | 0.072 |
HDL [n, (%)] | 181 (75.7%) | 62 (72.9%) | 119 (77.3%) | 0.455 | 181 (75.7%) | 62 (72.9%) | 119 (77.3%) | 0.455 |
BP [n, (%)] | 111 (46.6%) | 41 (48.2%) | 70 (45.8%) | 0.713 | 111 (46.6%) | 41 (48.2%) | 70 (45.8%) | 0.713 |
GLU [n, (%)] | 107 (44.8%) | 35 (41.2%) | 72 (46.8%) | 0.407 | 103 (43.1%) | 35 (41.2%) | 68 (44.2%) | 0.656 |
Number of MS criteria | ||||||||
0 | 8 (3.3) | 3 (3.5) | 5 (3.3) | 8 (3.4) | 3 (3.5) | 5 (3.3) | ||
1 | 29 (12.1) | 15 (17.6) | 14 (9.2) | 24 (10.1) | 11 (12.9) | 13 (8.5) | ||
2 | 72 (30.1) | 21 (24.7) | 51 (33.3) | 60 (25.29 | 19 (22.4) | 41 (26.8) | ||
3 | 67 (28.5) | 23 (27.1) | 44 (28.8) | 70 (29.4) | 22 (25.9) | 48 (31.4) | ||
4 | 48 (20.1) | 17 (20.0) | 31 (20.3) | 48 (20.2) | 20 (23.5) | 28 (18.3) | ||
5 | 14 (5.9) | 6 (7.1) | 8 (5.2) | 0.411 | 28 (11.8) | 10 (11.8) | 18 (11.8) | 0.718 |